David F. Schneider, MD, MS, FACS
- Division of Endocrine Surgery
600 Highland Ave
BX7375 Clinical Science Center
Madison, WI 53792-3284
- MD, Loyola Stritch School of Medicine, Chicago, IL, 2004
- Research Fellowship in Burn & Shock Trauma, Loyola Medical Center, Chicago, IL, 2008
- MS in Clinical Research Methods, Department of Preventive Medicine & Epidemiology, Loyola Stritch School of Medicine, 2010
- General Surgery Residency, Loyola Medical Center, Chicago, IL, 2011
- Fellowship in Endocrine Surgery, University of Wisconsin School of Medicine and Public Health, 2013
Dr. Schneider is certified by the American Board of Surgery, and he is a member of multiple specialty societies including the American Association of Endocrine Surgeons, the American Thyroid Association, the North American NeuroEndocrine Tumor Society, and the American Association of Clinical Endocrinologists. He specializes in endocrine surgery, treating diseases of the thyroid, parathyroid, and adrenal glands. He utilizes several minimally invasive techniques to treat endocrine disorders (endoscopic thyroidectomy, minimally invasive parathyroidectomy, laparoscopic adrenalectomy, focused exploration for recurrent thyroid cancer).
Dr. Schneider provides a wide range of services including Adrenal Surgery, Central Neck Dissection, Endocrine Surgery, Fine Needle Aspiration (FNA), Laparoscopic Adrenalectomy, Minimally Invasive Parathyroidectomy, Minimally Invasive Radioguided Parathyroidectomy (MIRP), Modified Radical Neck Dissection, Neck Ultrasound, Open Adrenalectomy, Parathyroid Surgery, Resection Of Substernal Goiter, Retroperitoneoscopic Adrenalectomy, Subtotal Parathyroidectomy, Thyroidectomy, Thyroid Lobectomy, Thyroid Surgery, Total Thyroidectomy.
Dr. Schneider conducts outcomes research in conjunction with the Wisconsin Surgical Outcomes Program. His research program investigates the optimization of cancer care in the United States with a particular interest in endocrine cancers. This work utilizes large national databases which can impact national healthcare and policy initiatives. He also conducts clinical research working on hyperparathyroidism, thyroid cancer, Graves’ Disease, and adrenal disorders.
- Identifying Predictors of Prolonged Levothyroxine Dose Adjustment After Thyroidectomy.
- Atruktsang TS, Zaborek NA, Imbus JR, Long K, Pitt SC, Sippel RS, Schneider DF
- J. Surg. Res. 2019 May 09; 242: 166-171
- [PubMed ID: 31078901]
- Failure to Diagnose and Treat Hyperparathyroidism Among Patients with Hypercalcemia: Opportunities for Intervention at the Patient and Physician Level to Increase Surgical Referral.
- Asban A, Dombrowsky A, Mallick R, Xie R, Kirklin JK, Grogan RH, Schneider DF, Chen H, Balentine CJ
- Oncologist 2019 Apr 24;
- [PubMed ID: 31019019]
- The optimal dosing scheme for levothyroxine after thyroidectomy: A comprehensive comparison and evaluation.
- Zaborek NA, Cheng A, Imbus JR, Long KL, Pitt SC, Sippel RS, Schneider DF
- Surgery 2019 Jan; 165(1): 92-98
- [PubMed ID: 30413325]
- Timely Evaluation and Management of Primary Hyperparathyroidism in Patients With Kidney Stones.
- Perez AA, Schneider DF, Long KL, Pitt SC, Sippel RS
- J. Surg. Res. 2018 12; 232: 564-569
- [PubMed ID: 30463775]
- Survival in patients with medullary thyroid cancer after less than the recommended initial operation.
- Randle RW, Bates MF, Schneider DF, Sippel RS, Pitt SC
- J Surg Oncol 2018 May; 117(6): 1211-1216
- [PubMed ID: 29266278]